Eli Lilly & Co. (LLY)
990.26
-7.33
(-0.73%)
USD |
NYSE |
Dec 09, 14:39
Eli Lilly Total Liabilities (Quarterly): 91.08B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 80.52B |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
| Adverum Biotechnologies, Inc. | 128.05M |
| Viking Therapeutics, Inc. | 26.38M |
| Moderna, Inc. | 2.805B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.94B |
| Shareholders Equity (Quarterly) | 23.79B |
| Debt to Equity Ratio | 1.786 |
| Current Ratio | 1.546 |
| Net Debt Paydown Yield | -0.40% |